Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000602370 | SCV000713267 | uncertain significance | not specified | 2017-11-13 | criteria provided, single submitter | clinical testing | Variant classified as Uncertain Significance - Favor Pathogenic. The p.Gly510Glu variant in TBC1D24 has now been reported in trans with a likely pathogenic TBC1 D24 variant in one individual with hearing loss (LMM data). It has been identifi ed in 1/52804 of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs755880523). Computational prediction to ols and conservation analysis suggest that the p.Gly510Glu variant may impact th e protein, though this information is not predictive enough to determine pathoge nicity. In summary, while there is some suspicion for a pathogenic role, the cli nical significance of this variant is uncertain. ACMG/AMP Criteria applied: PM2, PM3, PP3. |
Gene |
RCV002266992 | SCV002549638 | uncertain significance | not provided | 2022-01-12 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |